Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
Abstract The novel time‐limited combinations with the bcl‐2 inhibitor venetoclax can induce deep responses even in CLL cases with unusual and biologically aggressive presentations, like the skin masses of our patient.
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-07-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.4514 |
| _version_ | 1797859549142581248 |
|---|---|
| author | Maria Dimou Theodoros Iliakis Vasileios Paradalis Aikaterini Bitsani Marie‐Christine Kyrtsonis Panayiotis Panayiotidis |
| author_facet | Maria Dimou Theodoros Iliakis Vasileios Paradalis Aikaterini Bitsani Marie‐Christine Kyrtsonis Panayiotis Panayiotidis |
| author_sort | Maria Dimou |
| collection | DOAJ |
| description | Abstract The novel time‐limited combinations with the bcl‐2 inhibitor venetoclax can induce deep responses even in CLL cases with unusual and biologically aggressive presentations, like the skin masses of our patient. |
| first_indexed | 2024-04-09T21:31:19Z |
| format | Article |
| id | doaj.art-4ad7baa08ff74c5fbbaccb6a3fdcd472 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-04-09T21:31:19Z |
| publishDate | 2021-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-4ad7baa08ff74c5fbbaccb6a3fdcd4722023-03-27T08:34:51ZengWileyClinical Case Reports2050-09042021-07-0197n/an/a10.1002/ccr3.4514Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatmentMaria Dimou0Theodoros Iliakis1Vasileios Paradalis2Aikaterini Bitsani3Marie‐Christine Kyrtsonis4Panayiotis Panayiotidis5First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial Unit Laiko General Hospital Athens GreeceFirst Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial Unit Laiko General Hospital Athens GreeceFirst Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial Unit Laiko General Hospital Athens GreeceFirst Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial Unit Laiko General Hospital Athens GreeceFirst Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial Unit Laiko General Hospital Athens GreeceFirst Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial Unit Laiko General Hospital Athens GreeceAbstract The novel time‐limited combinations with the bcl‐2 inhibitor venetoclax can induce deep responses even in CLL cases with unusual and biologically aggressive presentations, like the skin masses of our patient.https://doi.org/10.1002/ccr3.4514CLL/SLLMRD negativityskin nodulestime‐limited treatmentvenetoclax |
| spellingShingle | Maria Dimou Theodoros Iliakis Vasileios Paradalis Aikaterini Bitsani Marie‐Christine Kyrtsonis Panayiotis Panayiotidis Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment Clinical Case Reports CLL/SLL MRD negativity skin nodules time‐limited treatment venetoclax |
| title | Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment |
| title_full | Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment |
| title_fullStr | Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment |
| title_full_unstemmed | Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment |
| title_short | Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment |
| title_sort | complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time limited venetoclax obinutuzumab treatment |
| topic | CLL/SLL MRD negativity skin nodules time‐limited treatment venetoclax |
| url | https://doi.org/10.1002/ccr3.4514 |
| work_keys_str_mv | AT mariadimou completeeradicationofchroniclymphocyticleukemiawithunusualskininvolvementofhighmitoticindexaftertimelimitedvenetoclaxobinutuzumabtreatment AT theodorosiliakis completeeradicationofchroniclymphocyticleukemiawithunusualskininvolvementofhighmitoticindexaftertimelimitedvenetoclaxobinutuzumabtreatment AT vasileiosparadalis completeeradicationofchroniclymphocyticleukemiawithunusualskininvolvementofhighmitoticindexaftertimelimitedvenetoclaxobinutuzumabtreatment AT aikaterinibitsani completeeradicationofchroniclymphocyticleukemiawithunusualskininvolvementofhighmitoticindexaftertimelimitedvenetoclaxobinutuzumabtreatment AT mariechristinekyrtsonis completeeradicationofchroniclymphocyticleukemiawithunusualskininvolvementofhighmitoticindexaftertimelimitedvenetoclaxobinutuzumabtreatment AT panayiotispanayiotidis completeeradicationofchroniclymphocyticleukemiawithunusualskininvolvementofhighmitoticindexaftertimelimitedvenetoclaxobinutuzumabtreatment |